CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.
This article summarizes epidemiological studies of inflammation markers, particularly C-reactive protein, and cardiovascular disease as of early 2002. Gaps in the research and the public health practice implications are also discussed. Although considerable work has been published since this review was completed, the perspectives and issues presented are still useful in evaluating the use of inflammation markers for risk stratisfication and prevention.
Fortmann
Stephen P
SP
Ford
Earl
E
Criqui
Michael H
MH
Folsom
Aaron R
AR
Harris
Tamara B
TB
Hong
Yuling
Y
Pearson
Thomas A
TA
Siscovick
David
D
Vinicor
Frank
F
Wilson
Peter F
PF
D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000592:standards; D011237:Predictive Value of Tests; D015980:Public Health Practice; D012016:Reference Values; D012306:Risk; D018570:Risk Assessment
D015415:Biomarkers; D002097:C-Reactive Protein